Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | DRD4 | P21917 | 3/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24137898 | 1.00 | MEN1 (0.62) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2077308 | 1.00 | MEN1 (0.62) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL11453952 | 0.88 | MGLL (0.52) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL51024 | 0.87 | MEN1 (0.69) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL51135 | 0.85 | MEN1 (0.67) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL450127 | 0.85 | DRD4 (0.53) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL8070541 | 0.84 | MEN1 (0.65) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9136546 | 0.84 | MEN1 (0.65) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL10487984 | 0.84 | MEN1 (0.65) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13423741 | 0.84 | MEN1 (0.65) | MEN1KMT2ASLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 364 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111217769-B | Method for synthesizing epoxy compound by catalyzing olefin epoxy by using nano alumina | 华南理工大学 | 2023-04-21 | — | — | CN | claimed |
| CN-111217769-A | Method for synthesizing epoxy compound by catalyzing olefin epoxidation through nano aluminum oxide | 华南理工大学 | 2020-06-02 | — | — | CN | claimed |
| CN-104448451-A | Thermoplastic elastomer composition | YOKOHAMA RUBBER CO LTD | 2015-03-25 | — | — | CN | claimed |
| CN-101462947-B | Preparation of (R) -4-phenyl-2-hydroxybutyrate | SHANGHAI BAIDING PHARMACEUTICAL TECHNOLOGY CO LTD | 2012-07-25 | — | — | CN | claimed |
| CN-101462947-A | Preparation of (R) -4-phenyl-2-hydroxybutyrate | SHANGHAI BAIDING PHARMACEUTICA (CN) | 2009-06-24 | — | — | CN | claimed |
| EP-2017334-A2 | Method of isolating P450 Gene | KNC Laboratories Co., Ltd (JP) | 2009-01-21 | — | — | EP | claimed |
| US-20080220419-A1 | Oligonucleotide primers/probes; cytochrome p450 monooxygenase enzyme system; expression vectors; kits | MARINE BIOTECHNOLOGY INSTITUTE CO., LTD. (JP) | 2008-09-11 | — | — | US | claimed |
| EP-1811029-A1 | METHOD OF ISOLATING P450 GENE | MARINE BIOTECHNOLOGY INSTITUTE CO., LTD. (JP) | 2007-07-25 | — | — | EP | claimed |
| WO-2000010994-A1 | PROCESS FOR THE PREPARATION OF 2-(ARYLOXYMETHYL)-2,5,7,8-TETRAMETHYLCHROMAN-6-OLS | SANKYO COMPANY, LIMITED (JP) | 2000-03-02 | — | — | WO | claimed |
| EP-0194523-B1 | HYDROPHOBIC, THERMOPLASTIC, FLOWABLE POLYAMIDE | BAYER AG (DE) | 1992-04-22 | — | — | EP | claimed |
| US-4066597-A | METHOD OF FINISHING SYNTHETIC ORGANIC FIBROUS MATERIAL, IN PARTICULAR OF PROVIDING IT WITH AN ANTISTATIC FINISH | CIBA-GEIGY CORPORATION (US) | 1978-01-03 | — | — | US | claimed |
| CN-115197175-B | Synthesis method for preparing beta-lactone by expanding ring and carbonylation of beta-lactone and alkylene oxide | 大连理工大学 | 2024-04-09 | — | — | CN | disclosed |
| US-11834538-B2 | Anionic graft polymerization onto an existing polymer chain by organometallic base activation | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-11781048-B2 | One-component thermosetting epoxy adhesive with improved adhesion | SIKA TECHNOLOGY AG (CH) | 2023-10-10 | — | — | US | disclosed |
| US-11781048-B2 | One-component thermosetting epoxy adhesive with improved adhesion | SIKA TECHNOLOGY AG (CH) | 2023-10-10 | — | — | US | disclosed |
| US-4078071-A | FUNGICIDES, BACTERICIDES, ANTIPROTOZOA AGENTS | SYNTEX (U.S.A.) INC. (US) | 1978-03-07 | — | — | US | disclosed |
| US-4075130-A | DIAMINES, TRIAMINES | TEXACO DEVELOPMENT CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |
| US-4060501-A | Novolak derivatives as defoamers | TEXACO DEVELOPMENT CORPORATION (US) | 1977-11-29 | — | — | US | disclosed |
| US-4045568-A | FUNGICIDES, BACTERICIDES, ANTIPROTOZOA AGENTS | SYNTEX (U.S.A.) INC. (US) | 1977-08-30 | — | — | US | disclosed |
| US-3939213-A | Preparation of polyalkoxyalkyl compounds | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080220419-A1 | Oligonucleotide primers/probes; cytochrome p450 monooxygenase enzyme system; expression vectors; kits | CYP4Z1, POR, CYP11B1 | MEN1 3795/4885KMT2A 2429/4885SLC6A2 2879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.